Literature DB >> 11570310

[Staging of colorectal cancer. Official recommendations of the Canadian Study Group on Preventive Medicine].

.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11570310      PMCID： PMC2018559     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  17 in total

1.  Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study.

Authors:  M Rasmussen; O Kronborg; C Fenger; O D Jørgensen
Journal:  Scand J Gastroenterol       Date:  1999-01       Impact factor: 2.423

2.  Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening.

Authors:  D P Berry; P Clarke; J D Hardcastle; K D Vellacott
Journal:  Br J Surg       Date:  1997-09       Impact factor: 6.939

3.  Colorectal cancer screening: clinical guidelines and rationale.

Authors:  S J Winawer; R H Fletcher; L Miller; F Godlee; M H Stolar; C D Mulrow; S H Woolf; S N Glick; T G Ganiats; J H Bond; L Rosen; J G Zapka; S J Olsen; F M Giardiello; J E Sisk; R Van Antwerp; C Brown-Davis; D A Marciniak; R J Mayer
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

Review 4.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.

Authors:  W Burke; G Petersen; P Lynch; J Botkin; M Daly; J Garber; M J Kahn; A McTiernan; K Offit; E Thomson; C Varricchio
Journal:  JAMA       Date:  1997-03-19       Impact factor: 56.272

5.  Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects.

Authors:  J D Hardcastle; W M Thomas; J Chamberlain; G Pye; J Sheffield; P D James; T W Balfour; S S Amar; N C Armitage; S M Moss
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

6.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

8.  Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register.

Authors:  S Bülow; C Bülow; T F Nielsen; L Karlsen; F Moesgaard
Journal:  Scand J Gastroenterol       Date:  1995-10       Impact factor: 2.423

9.  Protection by endoscopy against death from colorectal cancer. A case-control study among veterans.

Authors:  A D Müller; A Sonnenberg
Journal:  Arch Intern Med       Date:  1995-09-11

10.  Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing.

Authors:  J E Verne; R Aubrey; S B Love; I C Talbot; J M Northover
Journal:  BMJ       Date:  1998-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.